“C-Terminal-PEDF Reduces IC50 Doses and Chemoresistant Population of CD133 and BCRP1-Positve Cancer Stem Like Cells”. Journal of Analytical Oncology, vol. 2, no. 4, Dec. 2013, pp. 195-08, https://doi.org/10.6000/1927-7229.2013.02.04.2.